A citation-based method for searching scientific literature

Blaise Mathias Costa, Mark W Irvine, Guangyu Fang, Richard J Eaves, Marie Belen Mayo-Martin, Donald A Skifter, David E Jane, Daniel T Monaghan. J Pharmacol Exp Ther 2010
Times Cited: 69







List of co-cited articles
1172 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Glutamate receptor ion channels: structure, regulation, and function.
Stephen F Traynelis, Lonnie P Wollmuth, Chris J McBain, Frank S Menniti, Katie M Vance, Kevin K Ogden, Kasper B Hansen, Hongjie Yuan, Scott J Myers, Ray Dingledine. Pharmacol Rev 2010
79

A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors.
Praseeda Mullasseril, Kasper B Hansen, Katie M Vance, Kevin K Ogden, Hongjie Yuan, Natalie L Kurtkaya, Rose Santangelo, Anna G Orr, Phuong Le, Kimberly M Vellano,[...]. Nat Commun 2010
117
57


Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonists.
Cara A Mosley, Timothy M Acker, Kasper B Hansen, Praseeda Mullasseril, Karen T Andersen, Phuong Le, Kimberly M Vellano, Hans Bräuner-Osborne, Dennis C Liotta, Stephen F Traynelis. J Med Chem 2010
64
48

Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.
Ezio Bettini, Anna Sava, Cristiana Griffante, Corrado Carignani, Alberto Buson, Anna Maria Capelli, Michele Negri, Filippo Andreetta, Sergio A Senar-Sancho, Lorena Guiral,[...]. J Pharmacol Exp Ther 2010
100
44

Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.
David H Hackos, Patrick J Lupardus, Teddy Grand, Yelin Chen, Tzu-Ming Wang, Paul Reynen, Amy Gustafson, Heidi J A Wallweber, Matthew Volgraf, Benjamin D Sellers,[...]. Neuron 2016
108
40

NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease.
Pierre Paoletti, Camilla Bellone, Qiang Zhou. Nat Rev Neurosci 2013
37



Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors.
S Vicini, J F Wang, J H Li, W J Zhu, Y H Wang, J H Luo, B B Wolfe, D R Grayson. J Neurophysiol 1998
521
30

Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors.
Erkan Karakas, Noriko Simorowski, Hiro Furukawa. Nature 2011
231
30

Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators.
Timothy M Acker, Hongjie Yuan, Kasper B Hansen, Katie M Vance, Kevin K Ogden, Henrik S Jensen, Pieter B Burger, Praseeda Mullasseril, James P Snyder, Dennis C Liotta,[...]. Mol Pharmacol 2011
70
30

Subunit-selective allosteric inhibition of glycine binding to NMDA receptors.
Kasper B Hansen, Kevin K Ogden, Stephen F Traynelis. J Neurosci 2012
76
30


Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator.
Alpa Khatri, Pieter B Burger, Sharon A Swanger, Kasper B Hansen, Sommer Zimmerman, Erkan Karakas, Dennis C Liotta, Hiro Furukawa, James P Snyder, Stephen F Traynelis. Mol Pharmacol 2014
52
40

Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators.
Daniel T Monaghan, Mark W Irvine, Blaise Mathias Costa, Guangyu Fang, David E Jane. Neurochem Int 2012
65
30

NMDA receptor structures reveal subunit arrangement and pore architecture.
Chia-Hsueh Lee, Wei Lü, Jennifer Carlisle Michel, April Goehring, Juan Du, Xianqiang Song, Eric Gouaux. Nature 2014
312
28

Subunit arrangement and function in NMDA receptors.
Hiroyasu Furukawa, Satinder K Singh, Romina Mancusso, Eric Gouaux. Nature 2005
525
27

Control of NMDA receptor function by the NR2 subunit amino-terminal domain.
Hongjie Yuan, Kasper B Hansen, Katie M Vance, Kevin K Ogden, Stephen F Traynelis. J Neurosci 2009
154
27


Structure-activity relationships for allosteric NMDA receptor inhibitors based on 2-naphthoic acid.
Blaise Mathias Costa, Mark W Irvine, Guangyu Fang, Richard J Eaves, Maria Belen Mayo-Martin, Bodo Laube, David E Jane, Daniel T Monaghan. Neuropharmacology 2012
26
73

Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design.
Matthew Volgraf, Benjamin D Sellers, Yu Jiang, Guosheng Wu, Cuong Q Ly, Elisia Villemure, Richard M Pastor, Po-wai Yuen, Aijun Lu, Xifeng Luo,[...]. J Med Chem 2016
59
32

A steroid modulatory domain on NR2B controls N-methyl-D-aspartate receptor proton sensitivity.
Ming-Kuei Jang, Dale F Mierke, Shelley J Russek, David H Farb. Proc Natl Acad Sci U S A 2004
78
26

Subtype-dependence of N-methyl-D-aspartate receptor modulation by pregnenolone sulfate.
M Horak, K Vlcek, H Chodounska, L Vyklicky. Neuroscience 2006
75
26


Coumarin-3-carboxylic acid derivatives as potentiators and inhibitors of recombinant and native N-methyl-D-aspartate receptors.
Mark W Irvine, Blaise M Costa, Arturas Volianskis, Guangyu Fang, Laura Ceolin, Graham L Collingridge, Daniel T Monaghan, David E Jane. Neurochem Int 2012
24
75

Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines.
Laetitia Mony, Shujia Zhu, Stéphanie Carvalho, Pierre Paoletti. EMBO J 2011
108
24

Distinct functional and pharmacological properties of Triheteromeric GluN1/GluN2A/GluN2B NMDA receptors.
Kasper B Hansen, Kevin K Ogden, Hongjie Yuan, Stephen F Traynelis. Neuron 2014
184
24

Heteromeric NMDA receptors: molecular and functional distinction of subtypes.
H Monyer, R Sprengel, R Schoepfer, A Herb, M Higuchi, H Lomeli, N Burnashev, B Sakmann, P H Seeburg. Science 1992
23

The NMDA receptor as a target for cognitive enhancement.
Graham L Collingridge, Arturas Volianskis, Neil Bannister, Grace France, Lydia Hanna, Marion Mercier, Patrick Tidball, Guangyu Fang, Mark W Irvine, Blaise M Costa,[...]. Neuropharmacology 2013
162
23

NMDA receptors in clinical neurology: excitatory times ahead.
Lorraine V Kalia, Suneil K Kalia, Michael W Salter. Lancet Neurol 2008
295
21

Mechanism of differential control of NMDA receptor activity by NR2 subunits.
Marc Gielen, Beth Siegler Retchless, Laetitia Mony, Jon W Johnson, Pierre Paoletti. Nature 2009
229
21



Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiators.
Sommer S Zimmerman, Alpa Khatri, Ethel C Garnier-Amblard, Praseeda Mullasseril, Natalie L Kurtkaya, Stefka Gyoneva, Kasper B Hansen, Stephen F Traynelis, Dennis C Liotta. J Med Chem 2014
33
45

Activation of recombinant NR1/NR2C NMDA receptors.
Shashank M Dravid, Anand Prakash, Stephen F Traynelis. J Physiol 2008
77
20

NMDA receptor subunits: function and pharmacology.
Pierre Paoletti, Jacques Neyton. Curr Opin Pharmacol 2007
591
20

Synthesis and structure activity relationship of tetrahydroisoquinoline-based potentiators of GluN2C and GluN2D containing N-methyl-D-aspartate receptors.
Rose M Santangelo Freel, Kevin K Ogden, Katie L Strong, Alpa Khatri, Kathryn M Chepiga, Henrik S Jensen, Stephen F Traynelis, Dennis C Liotta. J Med Chem 2013
36
38

X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor.
Alexander I Sobolevsky, Michael P Rosconi, Eric Gouaux. Nature 2009
719
18

Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential.
Laetitia Mony, James N C Kew, Martin J Gunthorpe, Pierre Paoletti. Br J Pharmacol 2009
272
18

Molecular mechanism of pregnenolone sulfate action at NR1/NR2B receptors.
Martin Horak, Kamil Vlcek, Milos Petrovic, Hana Chodounska, Ladislav Vyklicky. J Neurosci 2004
66
19

Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles.
Kevin Erreger, Shashank M Dravid, Tue G Banke, David J A Wyllie, Stephen F Traynelis. J Physiol 2005
318
18


Mechanism of glutamate receptor desensitization.
Yu Sun, Rich Olson, Michelle Horning, Neali Armstrong, Mark Mayer, Eric Gouaux. Nature 2002
544
18

Modulation of triheteromeric NMDA receptors by N-terminal domain ligands.
Christopher J Hatton, Pierre Paoletti. Neuron 2005
186
18

New advances in NMDA receptor pharmacology.
Kevin K Ogden, Stephen F Traynelis. Trends Pharmacol Sci 2011
139
18

The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors.
Steven M Paul, James J Doherty, Albert J Robichaud, Gabriel M Belfort, Brian Y Chow, Rebecca S Hammond, Devon C Crawford, Andrew J Linsenbardt, Hong-Jin Shu, Yukitoshi Izumi,[...]. J Neurosci 2013
148
18

Allosteric modulators of NMDA receptors: multiple sites and mechanisms.
Shujia Zhu, Pierre Paoletti. Curr Opin Pharmacol 2015
102
18


Rationale for and use of NMDA receptor antagonists in Parkinson's disease.
Penelope J Hallett, David G Standaert. Pharmacol Ther 2004
170
17


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.